Octagon Capital Advisors LP 13D/13G Filings for OnKure Therapeutics, Inc. (OKUR)

Octagon Capital Advisors LP 13D and 13G filings for OnKure Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-28
4:03 pm
Unchanged
2024-10-0413GONKURE THERAPEUTICS, INC. CLAS
OKUR
Octagon Capital Advisors LP225,000
1.800%
0
(Unchanged)
Filing